Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence
Jin Wang1, David L McDonagh2, Lingzhong Meng3
1Department of Anesthesiology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Insights
Calcium channel blockers (CCBs) impact hemodynamics by affecting blood pressure and cardiac output. While CCBs show therapeutic benefits in acute care, further research is needed to fully link their hemodynamic effects with patient outcomes.
Area of Science:
- Cardiovascular Pharmacology
- Clinical Hemodynamics
Background:
- Calcium channel blockers (CCBs) are crucial in acute care for managing critical hemodynamic alterations.
- Their known effects include decreased blood pressure and increased cardiac output systemically, and improved organ blood flow regionally.
Purpose of the Study:
- To review the hemodynamic effects of CCBs.
- To examine the evidence linking these effects to patient outcomes in acute care settings.
- To identify gaps in current knowledge and suggest future research directions.
Main Methods:
- This is a narrative review of existing literature.
- The review synthesizes data on CCB hemodynamic actions and clinical outcome studies.
Main Results:
- CCBs demonstrate therapeutic efficacy in conditions like hypertensive crisis, myocardial infarction, and arrhythmias.
- Evidence suggests CCBs can improve organ blood flow and tissue oxygenation despite impairing autoregulation.
- A disconnect exists between documented hemodynamic effects and reported clinical outcomes.
Conclusions:
- CCBs offer significant benefits in acute care by modulating hemodynamics.
- Further investigation is required to bridge the gap between understanding CCB hemodynamic actions and their impact on patient outcomes.
- Future studies should focus on clarifying these links for optimized clinical application.
Abstract:
Calcium channel blockers (CCBs) exert profound hemodynamic effects via blockage of calcium flux through voltage-gated calcium channels. CCBs are widely used in acute care to treat concerning, debilitating, or life-threatening hemodynamic changes in many patients. The overall literature suggests that, for systemic hemodynamics, although CCBs decrease blood pressure, they normally increase cardiac output; for regional hemodynamics, although they impair pressure autoregulation, they normally increase organ blood flow and tissue oxygenation. In acute care, CCBs exert therapeutic efficacy or improve outcomes in patients with aneurysmal subarachnoid hemorrhage, acute myocardial infarction and unstable angina, hypertensive crisis, perioperative hypertension, and atrial tachyarrhythmia. However, despite the clear links, there are missing links between the known hemodynamic effects and the reported outcome evidence, suggesting that further studies are needed for clarification. In this narrative review, we aim to discuss the hemodynamic effects and outcome evidence for CCBs, the links and missing links between these two domains, and the directions that merit future investigations.
More Related Videos
10:53Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
